OpenEye will be attending and presenting at the Drug Discovery Conference in London.
Please join us on Monday, March 27 at 10:55 am as Anthony Nicholls, President and CEO from OpenEye presents:
Orion: CADD reimagined as a cloud enterprise
Orion is OpenEye’s reimagining of all the elements of CADD conducted entirely within a cloud service, in our case Amazon Web Services (AWS), delivered as either a hosted system or an in-house VPC solution
As a ‘cloud native’ platform Orion completely automates and manages access to large scale AWS processing and storage
In-cloud facilities include molecular design, 3D visualization, data analysis, results/method sharing and project organization
All of OpenEye science is included, enabling users to construct innovative workflows with Floe, our pipelining tool
As an open platform Orion allows for straightforward integration of third-party code (customer, academic, vendor)
Interaction with Orion is via a simple webpage, deliverable on any internet-enabled device